Halozyme plans USD 1.05 billion convertible senior notes offering due 2033

Halozyme announced a proposed offering of USD 1.05 billion convertible senior notes due 2033.

• The deal includes a 13-day option for initial purchasers to buy up to an additional USD 150 million of notes.
• Proceeds are expected to fund capped call transactions, reducing dilution tied to conversions.
• Part of the proceeds is earmarked to repurchase outstanding 0.25% convertible senior notes due 2027 and 1% convertible senior notes due 2028.
• The notes are expected to mature on Oct. 1, 2033; interest terms will be set at pricing.